2018 Q4 Form 10-Q Financial Statement
#000114420418060006 Filed on November 14, 2018
Income Statement
Concept | 2018 Q4 | 2018 Q3 | 2017 Q3 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.390M | $820.0K | $850.0K |
YoY Change | 26.36% | -3.53% | 325.0% |
% of Gross Profit | |||
Research & Development | $2.720M | $1.788M | $2.000M |
YoY Change | -47.89% | -10.6% | 992.9% |
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $4.100M | $1.788M | $2.848M |
YoY Change | -35.18% | -37.22% | 643.6% |
Operating Profit | -$2.608M | -$2.848M | |
YoY Change | -8.43% | 643.6% | |
Interest Expense | $10.00K | $0.00 | $106.0K |
YoY Change | -87.5% | -100.0% | 19.1% |
% of Operating Profit | |||
Other Income/Expense, Net | $180.0K | $0.00 | -$100.0K |
YoY Change | 119.51% | -100.0% | -37.89% |
Pretax Income | -$3.920M | -$2.600M | -$2.950M |
YoY Change | -37.18% | -11.86% | 446.3% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$3.920M | -$2.595M | -$2.948M |
YoY Change | -37.21% | -11.97% | 441.91% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$380.2K | -$252.4K | -$295.9K |
COMMON SHARES | |||
Basic Shares Outstanding | 10.66M shares | 10.55M shares | 10.04M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2018 Q4 | 2018 Q3 | 2017 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $2.670M | $4.800M | $26.05M |
YoY Change | -87.74% | -81.57% | 86733.33% |
Cash & Equivalents | $2.671M | $4.804M | $16.05M |
Short-Term Investments | $0.00 | $0.00 | $10.00M |
Other Short-Term Assets | $1.850M | $460.0K | $130.0K |
YoY Change | 374.36% | 253.85% | 333.33% |
Inventory | |||
Prepaid Expenses | $126.0K | ||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $4.530M | $5.260M | $26.18M |
YoY Change | -79.57% | -79.91% | 43533.33% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | -$5.000K | $3.000K | -$4.000K |
YoY Change | -175.0% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $4.530M | $5.260M | $26.18M |
Total Long-Term Assets | -$5.000K | $3.000K | -$4.000K |
Total Assets | $4.525M | $5.263M | $26.18M |
YoY Change | -79.59% | -79.89% | 43526.67% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.089M | $770.0K | $1.910M |
YoY Change | 99.94% | -59.69% | 377.5% |
Accrued Expenses | $2.070M | $1.700M | $80.00K |
YoY Change | 4040.0% | 2025.0% | -94.2% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | ||
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $5.156M | $2.469M | $1.990M |
YoY Change | 84.8% | 24.07% | -58.19% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $5.156M | $2.469M | $1.990M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $5.156M | $2.469M | $1.990M |
YoY Change | 84.8% | 24.07% | -73.64% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$42.21M | -$38.29M | -$14.42M |
YoY Change | 104.29% | 165.57% | |
Common Stock | $41.58M | $41.08M | $38.60M |
YoY Change | 6.78% | 6.42% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$631.0K | $2.794M | $24.19M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.525M | $5.263M | $26.18M |
YoY Change | -79.59% | -79.89% | 43526.67% |
Cashflow Statement
Concept | 2018 Q4 | 2018 Q3 | 2017 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$3.920M | -$2.595M | -$2.948M |
YoY Change | -37.21% | -11.97% | 441.91% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$1.240M | -$4.140M | -$1.870M |
YoY Change | -70.96% | 121.39% | 325.0% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | -$10.00M |
YoY Change | -100.0% | ||
Cash From Investing Activities | $0.00 | $0.00 | -$10.00M |
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -900.0K | 0.000 | -6.750M |
YoY Change | -100.0% | -1600.0% | |
NET CHANGE | |||
Cash From Operating Activities | -1.240M | -4.140M | -1.870M |
Cash From Investing Activities | 0.000 | 0.000 | -10.00M |
Cash From Financing Activities | -900.0K | 0.000 | -6.750M |
Net Change In Cash | -2.140M | -4.140M | -18.62M |
YoY Change | -49.88% | -77.77% | -186300.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.240M | -$4.140M | -$1.870M |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5096000 | USD | |
CY2018Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
13000 | USD |
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | ||
CY2018Q3 | atxi |
Common Stock Value Issuable
CommonStockValueIssuable
|
0 | USD |
CY2017Q4 | atxi |
Common Stock Value Issuable
CommonStockValueIssuable
|
1103000 | USD |
CY2018Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
41083000 | USD |
CY2017Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
38937000 | USD |
CY2018Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-38290000 | USD |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-20661000 | USD |
CY2018Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2794000 | USD |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19380000 | USD |
CY2018Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5263000 | USD |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
22170000 | USD |
CY2018Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2469000 | USD |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2790000 | USD |
CY2018Q3 | us-gaap |
Liabilities
Liabilities
|
2469000 | USD |
CY2017Q4 | us-gaap |
Liabilities
Liabilities
|
2790000 | USD |
CY2018Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2018Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | USD |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | USD |
CY2018Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4804000 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11782000 | USD |
CY2018Q3 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | USD |
CY2017Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
10000000 | USD |
CY2018Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
459000 | USD |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
388000 | USD |
CY2018Q3 | us-gaap |
Assets
Assets
|
5263000 | USD |
CY2017Q4 | us-gaap |
Assets
Assets
|
22170000 | USD |
CY2018Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2098000 | USD |
CY2017Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2737000 | USD |
CY2018Q3 | atxi |
Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
|
371000 | USD |
CY2017Q4 | atxi |
Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
|
53000 | USD |
CY2018Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1788000 | USD |
CY2017Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2000000 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14981000 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2580000 | USD | |
CY2018Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
820000 | USD |
CY2017Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
848000 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2733000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2516000 | USD | |
CY2018Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2608000 | USD |
CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2848000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-17714000 | USD | |
CY2018Q3 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
CY2017Q3 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
CY2017Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6000 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
85000 | USD | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6000 | USD | |
CY2018Q3 | us-gaap |
Interest Expense
InterestExpense
|
0 | USD |
CY2017Q3 | us-gaap |
Interest Expense
InterestExpense
|
106000 | USD |
us-gaap |
Interest Expense
InterestExpense
|
0 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
294000 | USD | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
81000 | USD | |
CY2018Q3 | atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
0 | USD |
CY2017Q3 | atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
0 | USD |
atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
0 | USD | |
atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
99000 | USD | |
CY2018Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
CY2017Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
451000 | USD | |
CY2018Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2595000 | USD |
CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2948000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-17629000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-6015000 | USD | |
CY2018Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.25 | |
CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.30 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.73 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.09 | ||
CY2018Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
10295958 | shares |
CY2017Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
9972663 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
10216466 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
5514988 | shares | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
0 | USD | |
atxi |
Share Issued During Period Valueon Exercise Of Warrants
ShareIssuedDuringPeriodValueonExerciseOfWarrants
|
0 | USD | |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1043000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1043000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
270000 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
174000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
71000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
126000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-639000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1408000 | USD | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
318000 | USD | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
360000 | USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-57000 | USD | |
atxi |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
0 | USD | |
atxi |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
-46000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-16978000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2534000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
10000000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10000000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
28387000 | USD | |
us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
-6978000 | USD | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD | |
us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
15853000 | USD | |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
197000 | USD |
CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
16050000 | USD |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
297000 | USD | |
atxi |
Issuance Of Common Shares For Founders Agreement
IssuanceOfCommonSharesForFoundersAgreement
|
0 | USD | |
atxi |
Issuance Of Common Shares For Founders Agreement
IssuanceOfCommonSharesForFoundersAgreement
|
948000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
37950000 | USD | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | USD | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3715000 | USD | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
0 | USD | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
1000000 | USD | |
atxi |
Warrants Issued
WarrantsIssued
|
0 | USD | |
atxi |
Warrants Issued
WarrantsIssued
|
750000 | USD | |
atxi |
Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
|
0 | USD | |
atxi |
Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
|
632000 | USD | |
atxi |
Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
|
0 | USD | |
atxi |
Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
|
300000 | USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
200000 | USD | |
atxi |
Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
|
0 | USD | |
atxi |
Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
|
15000 | USD | |
CY2016Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
250000 | shares |
CY2016Q3 | us-gaap |
Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
|
0.025 | pure |
CY2017 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
1100000 | USD |
CY2016 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
49000 | USD |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1391310 | shares | |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
984999 | shares | |
CY2018Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
770000 | USD |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1545000 | USD |
CY2018Q3 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
216000 | USD |
CY2017Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
215000 | USD |
CY2018Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1112000 | USD |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
977000 | USD |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
20000 | shares |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares | |
CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
20000 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.29 | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | ||
CY2018Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.29 | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y7M17D | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y10M17D | ||
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10265083 | shares |
CY2018Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10662398 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10265083 | shares |
us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
-10000000 | USD | |
us-gaap |
Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
|
10000000 | USD | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
3000000 | USD | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
0 | USD | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
2848000 | USD | |
CY2017Q4 | atxi |
Common Stock Shares Issuable
CommonStockSharesIssuable
|
273837 | shares |
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div></div><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin: 0px 0px 0px 0.05in; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: "times new roman", times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: "times new roman", times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; margin-right: 0px; background: none;"><div style="font-family: "times new roman", times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
CY2018Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2018Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10662398 | shares |
CY2018Q3 | atxi |
Common Stock Shares Issuable
CommonStockSharesIssuable
|
0 | shares |
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-09-30 | ||
CY2018Q3 | atxi |
Service Agreement Expenses
ServiceAgreementExpenses
|
100000 | USD |
atxi |
Service Agreement Expenses
ServiceAgreementExpenses
|
400000 | USD | |
CY2017Q3 | atxi |
Service Agreement Expenses
ServiceAgreementExpenses
|
100000 | USD |
atxi |
Service Agreement Expenses
ServiceAgreementExpenses
|
400000 | USD | |
CY2018Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2018Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
AVENUE THERAPEUTICS, INC. | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001644963 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Trading Symbol
TradingSymbol
|
ATXI | ||
CY2018Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
10662398 | shares |
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | ||
dei |
Entity Small Business
EntitySmallBusiness
|
false |